CHADS2 and CHA2DS2-VASc Risk Factors to Predict First Cardiovascular Hospitalization Among Atrial Fibrillation/Atrial Flutter Patients

被引:63
作者
Naccarelli, Gerald V. [1 ]
Panaccio, Mary Prince [3 ]
Cummins, Gordon [2 ]
Tu, Nora [3 ]
机构
[1] Penn State Milton S Hershey Med Ctr, Penn State Heart & Vasc Inst, Hershey, PA USA
[2] Quintiles, Hawthorne, NY USA
[3] Sanofi Aventis US, Bridgewater, NJ USA
关键词
STROKE; MORTALITY; PREVALENCE; TRENDS; DRONEDARONE; MANAGEMENT; EVENTS; BURDEN; UPDATE; COST;
D O I
10.1016/j.amjcard.2012.01.371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Limited data exist concerning risk factors for cardiovascular (CV) hospitalization in patients with atrial fibrillation (AF) or atrial flutter (AFL). The aim of this retrospective cohort evaluation was to assess whether patient characteristics and risk factors, including CHADS 2 (congestive heart failure, hypertension, age <75 years, type 2 diabetes, and previous stroke or transient ischemic attack [doubled]) and CHA 2DS 2-VASc (congestive heart failure; hypertension; age <75 years [doubled]; type 2 diabetes; previous stroke, transient ischemic attack, or thromboembolism [doubled]; vascular disease; age 65 to 75 years; and sex category) scores, identified patients with AF or AFL at risk for CV hospitalization. Claims data (January 2003 to June 2009) were evaluated to identify patients aged <40 years with <1 inpatient or <2 (within 30 days of each other) outpatient diagnoses of AF or AFL and an absence of diagnosis codes related to cardiac surgery within 30 days of AF or AFL diagnosis. Risk factors for first CV hospitalization in the 2-year period after diagnosis were assessed using univariate and multivariate analyses. Overall, 377,808 patients (mean age 73.9 ± 12.1 years) were identified, of whom 128,048 had CV hospitalizations. CHADS 2 and CHA 2DS 2-VASc scores were the top 2 predictors of first CV hospitalization after AF or AFL diagnosis. Hospitalization risk was increased 2.3- to 2.7-fold in patients with CHADS 2 scores of 6 and approximately 3.0-fold in patients with CHA 2DS 2-VASc scores of 9 compared to patients with a score of 0. These increases were maintained essentially unchanged throughout the 2-year follow-up period. In conclusion, CHADS 2 and CHA 2DS 2-VASc scores were predictive of first CV hospitalization in patients with AF or AFL and may be helpful in identifying at-risk" patients and guiding therapy. © 2012 Elsevier Inc."
引用
收藏
页码:1524 / 1531
页数:8
相关论文
共 27 条
  • [1] Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study
    Alonso, Alvaro
    Agarwal, Sunil K.
    Soliman, Elsayed Z.
    Ambrose, Marietta
    Chamberlain, Alanna M.
    Prineas, Ronald J.
    Folsom, Aaron R.
    [J]. AMERICAN HEART JOURNAL, 2009, 158 (01) : 111 - 117
  • [2] A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario
    Austin, PC
    Daly, PA
    Tu, JV
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (02) : 290 - 296
  • [3] Racial differences in the prevalence of atrial fibrillation among males
    Borzecki, Ann M.
    Bridgers, D. Keith
    Liebschutz, Jane M.
    Kader, Boris
    Kazis, Lewis E.
    Berlowitz, Dan R.
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (02) : 237 - 245
  • [4] Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation
    Boulanger, Luke
    Hauch, Ole
    Friedman, Mark
    Foster, Talia
    Dixon, Deirdre
    Wygant, Gail
    Menzin, Joseph
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1024 - 1029
  • [5] Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
  • [6] Atrial Fibrillation Significantly Increases Total Mortality and Stroke Risk Beyond that Conveyed by the CHADS2 Risk Factors
    Crandall, Mark A.
    Horne, Benjamin D.
    Day, John D.
    Anderson, Jeffrey L.
    Muhlestein, Joseph B.
    Crandall, Brian G.
    Weiss, J. Peter
    Osborne, Jeffrey S.
    Lappe, Donald L.
    Bunch, T. Jared
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (08): : 981 - 986
  • [7] 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
    Fuster, Valentin
    Ryden, Lars E.
    Cannom, Davis S.
    Crijns, Harry J.
    Curtis, Anne B.
    Ellenbogen, Kenneth A.
    Halperin, Jonathan L.
    Kay, G. Neal
    Le Huezey, Jean-Yves
    Lowe, James E.
    Olsson, S. Bertil
    Prystowsky, Eric N.
    Tamargo, Juan Luis
    Wann, L. Samuel
    Estes, N. A. Mark, III
    Ezekowitz, Michael D.
    Jackman, Warren M.
    January, Craig T.
    Page, Richard L.
    Slotwiner, David J.
    Stevenson, William G.
    Tracy, Cynthia M.
    Jacobs, Alice K.
    Anderson, Jeffrey L.
    Albert, Nancy
    Buller, Christopher E.
    Creager, Mark A.
    Ettinger, Steven M.
    Guyton, Robert A.
    Hochman, Judith S.
    Kushner, Frederick G.
    Ohman, Erik Magnus
    Tarkington, Lynn G.
    Yancy, Clyde W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (11) : E101 - E198
  • [8] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
    Gage, BF
    Waterman, AD
    Shannon, W
    Boechler, M
    Rich, MW
    Radford, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22): : 2864 - 2870
  • [9] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Chang, YC
    Henault, LE
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18): : 2370 - 2375
  • [10] Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
    Hohnloser, Stefan H.
    Crijns, Harry J. G. M.
    van Eickels, Martin
    Gaudin, Christophe
    Page, Richard L.
    Torp-Pedersen, Christian
    Connolly, Stuart J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) : 668 - 678